Ticker > Company >

Fortis Healthcare share price

Fortis Healthcare Ltd.

NSE: FORTIS BSE: 532843 SECTOR: Hospital & Healthcare Services  2.11 L   645   132

949.90
+1.90 (0.20%)
BSE: 05 Sep 04:01 PM

Price Summary

Today's High

₹ 961.85

Today's Low

₹ 942

52 Week High

₹ 971

52 Week Low

₹ 521.05

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

71713.47 Cr.

Enterprise Value

73442.61 Cr.

No. of Shares

75.5 Cr.

P/E

807.19

P/B

7.86

Face Value

₹ 10

Div. Yield

0.11 %

Book Value (TTM)

₹  120.88

CASH

49.45 Cr.

DEBT

1778.59 Cr.

Promoter Holding

31.17 %

EPS (TTM)

₹  1.18

Sales Growth

22.39%

ROE

0.7 %

ROCE

2.23%

Profit Growth

-68.02 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Fortis Healthcare Ltd.

SRL La-femme

Index Presence

The company is present in 26Indices.

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year22.39%
3 Year18.79%
5 Year15.55%

Profit Growth

1 Year-68.02%
3 Year89.58%
5 Year-34.1%

ROE%

1 Year0.7%
3 Year1.33%
5 Year0.78%

ROCE %

1 Year2.23%
3 Year2.67%
5 Year2.2%

Debt/Equity

0.196

Price to Cash Flow

214.7

Interest Cover Ratio

2.0254

CFO/PAT (5 Yr. Avg.)

2.4521079040015

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 31.17 0.00
Mar 2025 31.17 0.00
Dec 2024 31.17 0.00
Sep 2024 31.17 0.00
Jun 2024 31.17 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 89.5807839611589% for the Past 3 years.
  • The company has shown a good revenue growth of 18.7877863928583% for the Past 3 years.
  • The company has an efficient Cash Conversion Cycle of -527.2477 days.
  • The company has a good cash flow management; CFO/PAT stands at 2.4521079040015.

 Limitations

  • Company has a poor ROE of 1.33056666666667% over the past 3 years.
  • Company has a poor ROCE of 2.67363333333333% over the past 3 years
  • The company is trading at a high PE of 807.19.
  • The company is trading at a high EV/EBITDA of 149.9543.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 333.4 357.15 366.87 388.47 433.03
Total Expenditure 275.46 297.3 300.11 317.51 344.92
Operating Profit 57.94 59.85 66.76 70.96 88.11
Other Income 35.43 104.17 33.96 24.99 40.01
Interest 16.84 16.32 26.51 51.91 51.87
Depreciation 26.03 27.41 28.96 30.52 30.16
Exceptional Items 0 -68.28 5.56 -52.42 16.88
Profit Before Tax 50.5 52.01 50.81 -38.9 62.97
Tax 23.67 12.38 11.25 3.33 11.09
Profit After Tax 26.83 39.63 39.56 -42.23 51.88
Adjusted EPS (Rs) 0.36 0.52 0.52 -0.56 0.69

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 632.87 862.61 1052.93 1181.42 1445.89
Total Expenditure 604.96 747.21 919.78 988.62 1190.38
Operating Profit 27.91 115.41 133.15 192.81 255.5
Other Income 191.98 134.09 149.58 143 198.55
Interest 141.45 129.58 106.24 81.92 111.58
Depreciation 110.77 112.63 115.88 100.98 112.92
Exceptional Items 56.46 -16.28 48.29 93.65 -115.14
Profit Before Tax 24.13 -8.99 108.88 246.56 114.41
Tax 19.93 4.26 12.64 47.11 50.63
Net Profit 4.2 -13.25 96.24 199.45 63.78
Adjusted EPS (Rs.) 0.06 -0.18 1.27 2.64 0.84

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 754.96 754.96 754.96 754.96 754.96
Total Reserves 8126.57 8113.61 8208.58 8332.21 8319.04
Borrowings 663.78 585.52 281.58 254.05 1738.19
Other N/C liabilities 732.48 682.92 556.38 522.29 479.05
Current liabilities 472.51 462.74 644.66 760.13 994.7
Total Liabilities 10750.31 10599.75 10558.48 10623.65 12285.94
Assets
Net Block 852.83 770.28 491.86 467.31 924.97
Capital WIP 6.32 6.33 2.67 259.38 42.32
Intangible WIP 0.42 0 0 0.82 0.07
Investments 8898.47 8845.29 8847.6 8834.04 10178.25
Loans & Advances 605.51 570.78 525.56 420.23 750.14
Other N/C Assets 1.31 1.38 256.36 0.37 0.25
Current Assets 385.44 405.69 434.42 641.5 389.93
Total Assets 10750.31 10599.75 10558.48 10623.65 12285.94
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 24.13 -8.99 108.88 246.56 114.41
Adjustment 24.6 123.55 27.6 -46.82 149.3
Changes in Assets & Liabilities -7.28 10.72 95.53 41.77 68.28
Tax Paid -9.5 -48.79 -33.64 -23.06 2.03
Operating Cash Flow 31.94 76.49 198.38 218.45 334.02
Investing Cash Flow 28.4 237.74 204.62 44.46 -1572.21
Financing Cash Flow 5.91 -319.83 -395.43 -245.35 1275.91
Net Cash Flow 66.26 -5.6 7.57 17.56 37.72

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 31.17 31.17 31.17 31.17 31.17
northern tk venture pte. ... - - - 31.17 31.17
northern tk venture pte.l... - - 31.17 - -
northern tk venture pte. ... - 31.17 - - -
northern tk venture pte l... 31.17 - - - -
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 68.83 68.83 68.83 68.83 68.83
aditya birla sun life tru... 3.64 3.47 2.97 2.46 2.47
amansa holdings private l... 1.39 1.41 1.41 1.70 1.70
axis bank limited 1.19 1.19 1.19 1.19 1.19
axis elss tax saver fund - - - - 3.40
dsp nifty healthcare etf - - - - 1.29
edelweiss business cycle ... - - - - 1.01
fidelity funds - india fo... - 1.67 - 1.62 1.64
government pension fund g... - 1.23 1.14 - 1.04
hdfc mutual fund-hdfc arb... - - - - 5.68
jupiter india fund 1.85 1.86 1.81 1.52 1.38
kotak equity hybrid - - - - 5.14
kotak funds - india midca... 1.25 1.28 - 1.24 1.24
nippon life india trustee... - - - - 2.38
rekha jhunjhunwala 4.21 4.07 4.07 4.07 4.07
sbi life insurance co. lt... - - - 1.53 1.55
axis mutual fund trustee ... 3.15 3.29 3.46 3.40 -
dsp equity opportunities ... - - - 1.29 -
hdfc mutual fund - hdfc s... - - 5.86 6.00 -
kotak emerging equity sch... - - - 4.56 -
mirae asset nifty midcap ... - 1.77 - 1.33 -
nippon life india trustee... - 2.37 - 2.28 -
fidelity funds-india focu... 1.67 - 1.72 - -
kotak funds-india midcap ... - - 1.27 - -
kotak mahindra trustee co... - - 4.40 - -
mire asset elss tax saver... - - 1.54 - -
nippon life india trustee... - - 2.40 - -
sbi life insurance co.ltd... 2.47 1.42 1.40 - -
sbi long term equity fund... - 1.11 1.15 - -
hdfc mutual fund - hdfc n... - 5.56 - - -
kotak mahindra trustee co... - 5.28 - - -
sundaram mutual fund a/c ... - 1.13 - - -
hdfc mutual fund - hdfc b... 5.19 - - - -
kotak mahindra trustee co... 4.47 - - - -
mirae asset midcap fund 2.99 - - - -
nippon india trustee ltd-... 2.43 - - - -
sbi large & midcap fund 1.49 - - - -
sundaram mutual fund a/c ... 1.23 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2024
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit ICRA
Credit CRISIL
Credit CRISIL
Credit CARE
TYPE AGENCY Link
TYPE AGENCY Link
Research HDFC Securities
Research HDFC Securities
Research HDFC Securities
Research Ventura
Research Way2Wealth

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY24
Concall Q4FY23
Concall Q4FY22
Concall Q3FY25
Concall Q3FY24
Concall Q3FY20
Concall Q2FY24
Concall Q2FY21
Concall Q1FY25
Concall Q1FY24
Concall Q1FY21
Concall Q1FY20
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY24
Presentation Q4FY20
Presentation Q3FY25
Presentation Q3FY24
Presentation Q2FY24
Presentation Q2FY21
Presentation Q1FY25
Presentation Q1FY24
Presentation Q1FY24
Presentation Q1FY21
Presentation Q1FY20

Company News

Fortis Healthcare’s arm inks lease agreement with RR Lifesciences 2 Sep, 9:15 AM Fortis Healthcare signs collaboration agreement with Ekana Group 21 Aug, 9:16 AM Fortis Healthcare - Quaterly Results 6 Aug, 12:00 PM Fortis Healthcare - Quaterly Results 6 Aug, 12:00 PM Fortis Healthcare enters into O&M services agreement with GHIPL 23 Jul, 3:44 PM Fortis Healthcare informs about dividend payment 14 Jul, 5:37 PM Fortis Healthcare reports 7% fall in Q4 consolidated net profit 21 May, 2:23 PM Fortis Healthcare - Quaterly Results 20 May, 7:19 PM Fortis Healthcare - Quaterly Results 20 May, 7:19 PM Fortis Healthcare informs about reporting of debt securities 10 Apr, 11:54 AM Fortis Healthcare’s arm to acquire entire business operations of Shrimann Superspecialty Hospital 14 Feb, 4:25 PM Fortis Healthcare - Quaterly Results 7 Feb, 6:00 PM Fortis Healthcare - Quaterly Results 7 Feb, 6:00 PM Fortis Healthcare acquires 7.61% stake in Agilus Diagnostics 21 Dec, 12:29 PM Fortis Healthcare informs about outcome of committee meeting 19 Dec, 4:34 PM Fortis Healthcare - Quaterly Results 8 Nov, 5:32 PM Fortis Healthcare - Quaterly Results 8 Nov, 5:32 PM Fortis Healthcare - Quaterly Results 8 Nov, 5:32 PM Fortis Healthcare informs about change in directorate 23 Sep, 12:13 PM Fortis Healthcare informs about earnings call transcript 12 Aug, 1:32 PM Fortis Healthcare informs about disclosure 7 Aug, 12:14 PM Fortis Healthcare - Quaterly Results 6 Aug, 8:22 PM Fortis Healthcare - Quaterly Results 6 Aug, 8:22 PM Fortis Healthcare reports 47% rise in Q4 consolidated net profit 24 May, 2:26 PM Fortis Healthcare - Quaterly Results 23 May, 7:10 PM Fortis Healthcare - Quaterly Results 23 May, 7:10 PM Fortis Healthcare informs about disclosure 23 Feb, 5:21 PM Fortis Healthcare - Quaterly Results 7 Feb, 7:45 PM Fortis Healthcare - Quaterly Results 7 Feb, 7:45 PM Fortis Healthcare’s arm sells business operations in Chennai to MGM 2 Feb, 11:45 AM Fortis Healthcare reports 16% fall in Q2 consolidated net profit 13 Nov, 12:42 PM Fortis Healthcare - Quaterly Results 10 Nov, 6:30 PM Fortis Healthcare - Quaterly Results 10 Nov, 6:30 PM Fortis Healthcare informs about disclosure 30 Sep, 10:33 AM Fortis Healthcare informs about change in directorate 13 Sep, 5:14 PM Fortis Healthcare informs about voting results 8 Sep, 5:11 PM Fortis Healthcare - Quaterly Results 4 Aug, 8:06 PM Fortis Healthcare - Quaterly Results 4 Aug, 8:06 PM Fortis Healthcare partners with emergency response network RED.Health 27 Jun, 3:07 PM Fortis Healthcare inks pact for sale of hospital business operations at Vadapalani 22 Jun, 3:42 PM Fortis Healthcare informs about investor meetings 5 Jun, 12:48 PM Fortis Healthcare informs about disclosure 1 Jun, 4:18 PM Fortis Healthcare reports 59% rise in Q4 consolidated net profit 24 May, 11:14 AM Fortis Healthcare - Quaterly Results 23 May, 9:12 PM Fortis Healthcare - Quaterly Results 23 May, 9:12 PM Fortis Healthcare signs definitive agreements for acquisition of Medeor Hospital in Manesar 20 Apr, 2:30 PM Fortis Healthcare - Quaterly Results 10 Feb, 7:51 PM Fortis Healthcare - Quaterly Results 10 Feb, 7:51 PM Fortis Healthcare informs about closure of trading window 29 Dec, 4:49 PM Fortis Healthcare reports 67% rise in Q2 consolidated net profit 12 Nov, 12:55 PM

Fortis Healthcare Stock Price Analysis and Quick Research Report. Is Fortis Healthcare an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Fortis Healthcare. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Fortis Healthcare has a PE ratio of 805.446974847043 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Fortis Healthcare has ROA of 0.5568% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Fortis Healthcare has a Current ratio of 0.392.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Fortis Healthcare has a ROE of 0.7024%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Fortis Healthcare has a Debt to Equity ratio of 0.196 which means that the company has low proportion of debt in its capital.

  • Sales growth: Fortis Healthcare has reported revenue growth of 22.3851% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Fortis Healthcare for the current financial year is 17.6710717866564%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Fortis Healthcare is Rs 1 and the yield is 0.1055%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Fortis Healthcare is Rs 1.1768. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Fortis Healthcare in Ticker for free. Also, one can get the intrinsic value of Fortis Healthcare by using Valuation Calculators, which are available with a Finology ONE subscription. 

Fortis Healthcare FAQs

Q1. What is Fortis Healthcare share price today?
Ans: The current share price of Fortis Healthcare is Rs 947.85.

Q2. What is the market capitalisation of Fortis Healthcare?
Ans: Fortis Healthcare has a market capitalisation of Rs 71558.70805818 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Fortis Healthcare?
Ans: The PE ratio of Fortis Healthcare is 805.446974847043 and the P/B ratio of Fortis Healthcare is 7.84129292608412, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Fortis Healthcare share?
Ans: The 52-week high share price of Fortis Healthcare is Rs 971, and the 52-week low share price of Fortis Healthcare is Rs 542.15.

Q5. Does Fortis Healthcare pay dividends?
Ans: Currently, Fortis Healthcare pays dividends. Dividend yield of Fortis Healthcare is around 0.1055%.

Q6. What are the face value and book value of Fortis Healthcare shares?
Ans: The face value of Fortis Healthcare shares is Rs 10, while the book value per share of Fortis Healthcare is around Rs 120.8793. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Fortis Healthcare?
Ans: Fortis Healthcare has a total debt of Rs 1778.587 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Fortis Healthcare?
Ans: The ROE of Fortis Healthcare is 0.7024% and ROCE of Fortis Healthcare is 2.2314%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Fortis Healthcare a good buy for the long term?
Ans: The Fortis Healthcare long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Fortis Healthcare undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Fortis Healthcare appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Fortis Healthcare’s financials?
Ans: You can review Fortis Healthcare’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Fortis Healthcare

Fortis Healthcare Ltd. Financials: Check Share Price, Balance Sheet, Annual Report and Quarterly Results for Company Analysis

 

Fortis Healthcare Ltd. is a leading healthcare provider in India that offers a wide range of medical services. As a long-term stock investor, it is important to understand the company's financial health and performance to make informed investment decisions.  We will analyze Fortis Healthcare Ltd.'s stock using various parameters such as share price, balance sheet, annual report, dividend, quarterly result, stock price, price chart, news, concall, transcripts, investor presentations, promoters, and shareholders.

Fortis Healthcare Ltd Share Price

Fortis Healthcare Ltd.'s share price has seen a steady rise in the past few years. The company's share price has been hovering around Rs. 200-250 in the last year. However, it is important to note that the share price can be volatile in the short term and investors should focus on long-term trends.

Fortis Healthcare Ltd Balance Sheet

Fortis Healthcare Ltd.'s balance sheet shows a healthy financial position. The company has a strong asset base and a low debt-to-equity ratio. The company's pre-built screening tools such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis can be used to calculate the fair value of the stock.

Fortis Healthcare Ltd Annual Report

Fortis Healthcare Ltd.'s annual report provides a detailed overview of the company's financial performance, business strategy, and future plans. The annual report is available for download on Ticker. Investors can use the information in the annual report to make informed investment decisions.

Fortis Healthcare Ltd Dividend

Fortis Healthcare Ltd. has a consistent dividend payout history. The company has been paying dividends regularly for the past few years. However, it is important to note that the dividend payout can be affected by various factors such as the company's financial performance, future plans, and market conditions.

Fortis Healthcare Ltd Quarterly Result

Fortis Healthcare Ltd.'s quarterly results provide a snapshot of the company's financial performance in the short term. The company's pre-built screening tools such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis can be used to analyze the quarterly results.

Fortis Healthcare Ltd Stock Price

Fortis Healthcare Ltd.'s stock price can be affected by various factors such as the company's financial performance, market conditions, and investor sentiment. It is important to focus on long-term trends and use pre-built screening tools to analyze the stock price.

Fortis Healthcare Ltd Price Chart

Fortis Healthcare Ltd.'s price chart provides a visual representation of the company's stock price over time. The price chart can be used to identify long-term trends and patterns in the stock price.

Fortis Healthcare Ltd News

Fortis Healthcare Ltd.'s news section provides the latest updates about the company's financial performance, business strategy, and future plans. Investors can use the news section to stay updated about the company's developments.

Fortis Healthcare Ltd Concall

Fortis Healthcare Ltd.'s concall provides an opportunity for investors to interact with the company's management and ask questions about the company's financial performance, business strategy, and future plans. Investors can use the concall to get a better understanding of the company's operations.

Fortis Healthcare Ltd Transcripts

Fortis Healthcare Ltd.'s transcripts provide a detailed record of the company's concall. The transcripts can be used to analyze the company's responses to investors' questions and get a better understanding of the company's operations.

Fortis Healthcare Ltd Investor Presentations

Fortis Healthcare Ltd.'s investor presentations provide a detailed overview of the company's financial performance, business strategy, and future plans. The investor presentations can be used to make informed investment decisions.

Fortis Healthcare Ltd Promoters

Fortis Healthcare Ltd.'s promoters are the individuals or entities that hold a significant stake in the company. The promoters play a key role in the company's decision-making process and can influence the company's operations.

Fortis Healthcare Ltd Shareholders

Fortis Healthcare Ltd.'s shareholders are the individuals or entities that hold a stake in the company. The shareholders can influence the company's decision-making process through voting rights and can benefit from the company's financial performance through dividends and capital appreciation.

Fortis Healthcare Ltd ROCE

Fortis Healthcare Ltd ROCE (Return on Capital Employed) is a financial metric that assesses the company's effectiveness in generating profits from its capital investments. By analyzing the ROCE data for Fortis Healthcare Ltd available on this page, investors can evaluate the company's capital utilization and profitability. Detailed ROCE data can be found in the financials table or ratio section provided above.

Fortis Healthcare Ltd EBITDA

Fortis Healthcare Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is a key metric that helps understand the company's operational profitability. By excluding non-operating expenses, EBITDA provides insights into the core business performance of Fortis Healthcare Ltd. Investors can access the EBITDA data for the company in the financials table or ratio section above.

Fortis Healthcare Ltd DPS

Fortis Healthcare Ltd DPS (Dividends Per Share) represents the cash distributed to shareholders for each share held in the company. Understanding the DPS data helps investors evaluate the company's dividend policy and potential returns. Detailed DPS information for Fortis Healthcare Ltd can be found in the financials table or ratio section available above.

Fortis Healthcare Ltd EPS

Fortis Healthcare Ltd EPS (Earnings Per Share) is a crucial metric that indicates the company's profitability on a per-share basis. By analyzing the EPS data, investors can assess the company's earning potential and performance. Access the detailed EPS data for Fortis Healthcare Ltd in the financials table or ratio section provided above. 

Fortis Healthcare Equity and Liabilities Review

Fortis Healthcare Share Capital

Fortis Healthcare's share capital remains constant over five years from Mar 2020 to Mar 2024 at Rs 754.96 Cr., indicating no additional equity dilution.

Fortis Healthcare Total Reserves

Total reserves of Fortis Healthcare showed a gradual increase from Rs 8,121.51 Cr. in Mar 2020 to Rs 8,332.21 Cr. in Mar 2024, portraying a steady internal growth.

Fortis Healthcare Borrowings

The company's borrowings have significantly dropped from Rs 621.35 Cr. in Mar 2020 to Rs 254.05 Cr. in Mar 2024, showcasing a strong focus on debt reduction.

Fortis Healthcare Current Liabilities

An increasing trend in current liabilities from Rs 468.51 Cr. in Mar 2020 to Rs 760.13 Cr. in Mar 2024 indicates a rise in short-term obligations.

Fortis Healthcare Assets Analysis

Fortis Healthcare Investments

Investments have seen a nominal increase from Rs 8,153.11 Cr. in Mar 2020 to Rs 8,834.04 Cr. in Mar 2024, signifying a stable investment strategy.

Fortis Healthcare Net Block and Capital WIP

A significant decrease in Net Block combined with an unusual rise in Capital WIP in Mar 2024 to Rs 259.38 Cr. suggests a potential phase of expansion or asset upgrade.

Fortis Healthcare Current Assets

Current assets observed a robust increase, potentially underlining a growth in operational efficiency or inventory.

This data is an analysis for the Standalone Balance sheet of the company.

Fortis Healthcare plays a pivotal role in the healthcare sector; investors may also explore similar sectors for diversification in their portfolio.

Read More
X